MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

February 25, 2016

After a recent large fire destroyed the makeshift shelters and belongings of at least 449 families in the Batangafo displaced persons camp, one of the largest in Central African Republic (CAR), Doctors Without Borders/Médecins Sans Frontières (MSF) teams rapidly organized to distribute emergency kits including cooking and hygiene items for those affected.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

February 25, 2016

After a recent large fire destroyed the makeshift shelters and belongings of at least 449 families in the Batangafo displaced persons camp, one of the largest in Central African Republic (CAR), Doctors Without Borders/Médecins Sans Frontières (MSF) teams rapidly organized to distribute emergency kits including cooking and hygiene items for those affected.

September 15, 2014

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.